Suven Life Sciences Ltd. News and Updates

Name: Latest research reports of Suven Life Sciences Ltd. authored by Emkay and published by - Trendlyne research reports.
Item: Suven Life Sciences Ltd.
Rating: 5
Author: Emkay

Keep track of all breaking news on Suven Life Sciences Ltd. from all sources in a single place.

Load latest

Suven Life Sciences Ltd.

16 Nov 2018

119.33

-2.00%

Suven's (SVLS) weak Q2 numbers were driven by the absence of commercial CRAM supplies and...

Buy: Suven Life Sciences Ltd.

Target

Emkay

supplies and a little, but insignificant, supply of Specialty CRAMS. 1HFY19 results broadly tracked expected growth trends overall, with CRAMS revenues up by c.9% to Rs2.5bn, Core CRAMS to Rs1.6bn (Rs910mn in Q1, Rs720mn in Q2), Commercial CRAMS...

Suven Life Sciences Ltd. is trading above its 30 day SMA of 119.0

Suven Life Sciences Ltd.

13 Nov 2018

119.33

-2.00%

Suven Life gets product patents from Australia, Hong Kong

Business Line

Suven Life Sciences on Tuesday said it has been granted a product patent each by Australia and Hong Kong for a new chemical entity (NCE) for the treat

Suven Life Sciences Ltd.'s price crossed below 50Day SMA today

Suven Life Sciences Ltd.

06 Nov 2018

119.33

-2.00%

Suven Life gets product patents from Israel, Japan

Business Line

Suven Life Sciences Tuesday said it has been granted a product patent each by Israel and Japan, for a new chemical entity (NCE) that is used in the

Suven Life Sciences Ltd. is trading above its 30 day SMA of 119.0

Suven Life Sciences Ltd.

10 Oct 2018

119.33

-2.00%

Suven Life Sciences

Buy: Suven Life Sciences Ltd.

ICICI Securities Limited

Suven Life Sciences Ltd.'s price crossed below 50Day SMA today

Suven Life Sciences Ltd.

25 Sep 2018

119.33

-2.00%

Company news: Suven Life Sciences

Business Line

Suven Life Sciences on Tuesday informed the exchanges of the receipt of one product patent from Canada and another from Sri Lanka for the new chemical

Suven Life Sciences Ltd. is trading below its 50 day SMA of 120.5

Suven Life gets product patents from Canada, Sri Lanka

Business Line | 25 Sep 2018

Suven Life Sciences Ltd.

14 Sep 2018

119.33

-2.00%

Suven secures product patents in New Zealand, Sri Lanka

Business Line

Suven Life Sciences on Friday said it has been granted a product patent by New Zealand and Sri Lanka corresponding to a new chemical entity (NCE) for

Suven Life Sciences Ltd.'s price crossed below 50Day SMA today

Suven Life Sciences Ltd.

11 Sep 2018

119.33

-2.00%

Suven Life Sciences nears record high; stock surges 30% in one week

Business Standard

The stock hit a 52-week high of Rs 338, rallied 88% in past four months, trading close to its record high of Rs 339 touched on April 15, 2015 on the BSE.

Suven Life Sciences Ltd.'s price crossed below 50Day SMA today

Suven Life Sciences Ltd.

04 Sep 2018

119.33

-2.00%

Suven Life Sci

Buy: Suven Life Sciences Ltd.

Arihant Capital

Suven Life Sciences (SLS) is a compelling play on the recovery being witnessed in global R&D; spending, as reflected in strong fund raising by biotech start-ups as well as a fast-growing research pipeline across multiple stages of clinical trials. SLS has witnessed strong growth in revenue of 22.6% CAGR, whereas operating profit has shown growth of 42.4% CAGR over FY11 to FY18. With improved operating efficiency, we expect the EBITDA margin to expand at a higher rate than the gross margin due to lower than average R&D;...